Boston Scientific (BSX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Boston Scientific successfully continues its expansion of operations across different geographies outside the United States.
In the most recent trading session, Boston Scientific (BSX) closed at $91.29, indicating a +0.66% shift from the previous trading day.
Here is how Boston Scientific (BSX) and Aclarion, Inc. (ACON) have performed compared to their sector so far this year.
Five non-technology high-flyers of 2024 have the potential to fly higher in the short term. These are: CMG, IBKR, KKR, FI, BSX.
Investors continue to be optimistic about BSX, courtesy of its international expansion efforts and WATCHMAN's performance.
Boston Scientific (BSX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Boston Scientific closes the year at historic highs, with investors refusing to liquidate even at these levels. The smooth upward movement of the stock indicates the quality of its investor base. Strong profit margins and robust growth expectations for the short-term future make me overlook its high valuation.
In the closing of the recent trading day, Boston Scientific (BSX) stood at $89.68, denoting a -1.08% change from the preceding trading day.
In the most recent trading session, Boston Scientific (BSX) closed at $91.07, indicating a +1.35% shift from the previous trading day.
Medical stocks are expected to reap the benefits of affordable health insurance plans, rising surgeries and widespread adoption of telehealth services in the days ahead. However, inflation and supply-chain woes may act as spoilsport.
Boston Scientific (BSX) reachead $89.86 at the closing of the latest trading day, reflecting a +1.02% change compared to its last close.